vimarsana.com
  1. Home
  2. Live Updates
  3. Susanc Modesitt - Breaking News

Latest Breaking News On - Susanc modesitt - Page 1 : vimarsana.com

Modesitt Spotlights the Latest ADC Breakthroughs in Gynecologic Oncology

Susan C. Modesitt, MD, FACOG, FACS, sheds light on the latest research with antibody-drug conjugates across gynecologic cancers.

Emory universityUnited statesSusanc modesittNational comprehensive cancer networkWinship cancer institute of emory universityOnclive stateScience summitWinship cancer instituteGynecologic oncologyEmory university schoolAntibody drug conjugatesOnclive state of the science summitTrop2 and her2 targeted adcsMinimizing toxicitiesMirvetuximab soravtansineTrastuzumab deruxtecan

Dr Modesitt on Shared Decision-Making When Choosing PARP Inhibitors in Ovarian Cancer

Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer.

Susanc modesittDivision of gynecologic oncologyEmory university school of medicineDepartment of gynecologyGynecologic oncologyEmory university school

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.